A CBS investigation raises questions about products marketed as Lilly's experimental obesity drug, with two deaths reported after their use.
Recap by typeshit. Post by @physiciansfamepodcasts on Instagram.
Mounjaro became India's top-selling drug in 2025, and a Scroll investigation reports that pharmacies are handing it out without the prescription it requires.
The Sunrise health expert says unregulated peptide use can put people in hospital, and in the worst cases leave them needing a new liver.
Some people on weight loss drugs are testing lower doses, hoping for fewer side effects. ThePrint reports on the trend, which these users describe themselves.
Bell raises the question of muscle loss for people losing weight on a GLP-1 and notes it isn't medical advice, pointing viewers to their doctor.
A Facebook post covers what GLP-1 weight loss drugs can mean for people booked in for a gastroscopy or colonoscopy.
Researchers found about three to four extra cases of ischemic optic neuropathy per 10,000 patients over 18 months, mostly in men and people aged 50 to 65.
Loading…